J. Safra Asset Management’s Guardant Health GH Stock Holding History

J. Safra Asset Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.4K	Buy	109 +90	+474%	+$9.79K	﹤0.01%	344
2026 Q1	$1.75K	Buy	+19	New	+$1.91K	﹤0.01%	605
2023 Q1	–	Sell	-25	Closed	–	–	112
2022 Q4	$0	Buy	+25	New	+$1.14K	﹤0.01%	78

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

J. Safra Asset Management's GH Position: Q2 2026 in Review

J. Safra Asset Management increased its Guardant Health (GH) stake by 474% in Q2 2026, buying an estimated $9.79K and bringing the position to 109 shares worth $16.4K. The position accounts for ﹤0.01% of the portfolio, ranked #344.

J. Safra Asset Management first reported a position in GH in Q4 2022 and has held it in 3 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

J. Safra Asset Management held 109 shares of Guardant Health worth $16.4K as of Q2 2026.
J. Safra Asset Management bought 90 Guardant Health shares in Q2 2026, an estimated $9.79K.
Guardant Health made up ﹤0.01% of J. Safra Asset Management's portfolio in Q2 2026, its #344 holding.
J. Safra Asset Management first reported a position in Guardant Health in Q4 2022 and has held it in 3 quarters since.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.